The rising frequency of Parkinson's disease and epilepsy is predicted to drive up demand for DBS devices. Major market players are focusing on the approval and introduction of new DBS devices to extend their product portfolio, and key market players are focusing on the market launch of updated versions of their previously authorised DBS devices, which is projected to promote market growth. One of the major reasons impeding the growth of the global deep brain stimulation device market is the related hazards connected with deep brain stimulation operations such as lead misplacement and brain haemorrhage. The implanted pulse generator, for example, is the primary power source and programmable component of DBS devices (IPG). The use of deep brain stimulation devices for Parkinson's disease is expected to be limited because to the risk of infection caused by IPG. As a result, healthcare stakeholders should educate patients on the usage of tack-up sutures and low-profile devices, as well as antimicrobial impregnation and co-administration.
According to Coherent Market Insights, Global Deep Brain Stimulation Device Market size was valued at US$ 1,188.9 million in 2022 and is expected to witness a CAGR of 9.8% over the forecast period (2022 – 2030).
Key Leaders in the Deep Brain Stimualtion Industry: